Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial
Top Cited Papers
- 17 June 2010
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 376 (9736), 173-179
- https://doi.org/10.1016/s0140-6736(10)60673-3
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- OARSI recommendations for the management of hip and knee osteoarthritisOsteoarthritis and Cartilage, 2010
- EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritisAnnals Of The Rheumatic Diseases, 2009
- Intestinal permeability in the pathogenesis of NSAID-induced enteropathyThe Esophagus, 2009
- OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelinesOsteoarthritis and Cartilage, 2008
- Summing the risk of NSAID therapyThe Lancet, 2007
- Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopyAlimentary Pharmacology & Therapeutics, 2007
- EULAR evidence based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)Annals Of The Rheumatic Diseases, 2007
- Celecoxib Versus Naproxen and Diclofenac in Osteoarthritis Patients: SUCCESS-I StudyAmerican Journal Of Medicine, 2006
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988